Sravan Kumar Emany
Chief Financial OfficerMr. Sravan Kumar Emany is Independent Director of Kyverna Therapeutics, Inc. from February 24, 2026. He is Chief Financial Officer of Beam Therapeutics Inc. from December 19, 2024. Mr. Emany serves as Independent Director of Assertio Holdings, Inc. since November 2023. He served as Senior Vice President and Chief Financial Officer at Ironwood Pharmaceuticals, Inc. since December 6, 2021 until December 18, 2024 and was its Chief Operating Officer since June 18, 2024 until December 18, 2024. He joined the Ironwood Pharmaceuticals, Inc. in December 2021. Mr. Emany served as Corporate Vice President of Commercial Excellence & Chief Strategy Officer at Integra LifeSciences Corporation. Mr. Emany served as Corporate Vice President, Commercial Excellence and Chief Strategy Officer of Integra LifeSciences Holdings Corporation, a publicly traded global healthcare company, from March 2020 until December 2021 and as Vice President of Strategy, Treasury and Investor Relations from February 2018 to March 2020. Mr. Emany joined Integra in 2018 as vice president of strategy, treasury and investor relations. He served as Senior Vice President of Strategy & Investor Relations at Integra LifeSciences Holdings Corporation and was its Vice President of Investor Relations and Treasurer since February 26, 2018. Mr. Emany was Managing Director in the Mergers & Acquisitions group at Bank of America Merrill Lynch. While at Bank of America Merrill Lynch, he led numerous mergers and acquisitions in the healthcare sector, including the recent Integra acquisitions of Codman Neurosurgery and Derma Sciences. Mr. Emany served in various mergers and acquisitions investment banking roles at Bank of America and BofA Securities (formerly Bank of America Merrill Lynch) from September 2008 to February 2018. Prior to this role, he assumed positions of increasing responsibility in mergers and acquisitions and investment banking at other firms, including Goldman Sachs and Morgan Stanley. He holds an M.A. in International Relations and International Economics from The Johns Hopkins School of Advanced International Studies and a B.A. in International Relations from The Johns Hopkins University.
Positions
- Company NameBeam Therapeutics Inc.Stock CodeBEAMPositionChief Financial OfficerColleagues
- JMJohn M. EvansCEO & Director
- GCGiuseppe CiaramellaPresident
- CPChristine P. BellonChief Legal Officer & Corporate Secretary
- ASAmy SimonChief Medical Officer
- GKGraham K. CooperIndependent Director
- JMJohn Michael MaraganoreIndependent Director
- CGChirfi GuindoIndependent Director
- MCMark C. FishmanIndependent Lead Director
- Company NameKyverna Therapeutics, Inc.Stock CodeKYTXPositionIndependent DirectorColleagues
- CLChristi L. ShawExecutive Chairperson
- WBWarner BiddleCEO & Director
- NHNaji H. GehchanChief Medical & Development Officer
- GMGregory MartiniChief Financial Officer
- TVTom Van BlarcomSenior VP & Head of Research
- BCBeth C. SeidenbergIndependent Director
- ITIan T. ClarkIndependent Director
- SKSravan Kumar EmanyIndependent Director
